Transgenic overexpression of human LY6K in mice suppresses mature T cell development in the thymus
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Son, Dasom | - |
dc.contributor.author | Kong, Hyun-Kyung | - |
dc.contributor.author | Kim, Yesol | - |
dc.contributor.author | Song, Min-Ji | - |
dc.contributor.author | Kim, Hyong Pyo | - |
dc.contributor.author | Lee, Han Woong | - |
dc.contributor.author | Park, Jong Hoon | - |
dc.date.available | 2021-02-22T06:46:12Z | - |
dc.date.issued | 2019-01 | - |
dc.identifier.issn | 1792-1074 | - |
dc.identifier.issn | 1792-1082 | - |
dc.identifier.uri | https://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/3862 | - |
dc.description.abstract | Lymphocyte antigen 6 family member K (LY6K) is upregulated in a number of types of cancer and promotes tumor cell proliferation and metastasis. In addition, LY6K is involved in tamoxifen resistance in breast cancer. However, the in vivo molecular mechanism of LY6K has not yet been investigated. In the present study, transgenic mice overexpressing human LY6K (hLY6K) were generated using the pMAMneo vector, and the effect of LY6K upregulation in vivo was investigated. A total of 4 transgenic mice were generated, and the gene copy number was examined using reverse transcription-quantitative polymerase chain reaction (RT-qPCR). RT-qPCR demonstrated that mRNA of hLY6K was overexpressed in the thymus and spleen of the transgenic mice compared with wild-type mice. Flow cytometric analysis demonstrated that the proportions of B and T cells in the spleen were similar in wild-type and transgenic mice; however, the proportion of thymic mature T cells decreased in the transgenic mice, while there was an increase in the proportion of naive T cells. These findings suggest that the overexpression of LY6K suppresses T cell development, and that LY6K is a potential therapeutic target for cancer. | - |
dc.format.extent | 9 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | SPANDIDOS PUBL LTD | - |
dc.title | Transgenic overexpression of human LY6K in mice suppresses mature T cell development in the thymus | - |
dc.type | Article | - |
dc.publisher.location | 그리이스 | - |
dc.identifier.doi | 10.3892/ol.2018.9548 | - |
dc.identifier.scopusid | 2-s2.0-85057482079 | - |
dc.identifier.wosid | 000454845500047 | - |
dc.identifier.bibliographicCitation | ONCOLOGY LETTERS, v.17, no.1, pp 379 - 387 | - |
dc.citation.title | ONCOLOGY LETTERS | - |
dc.citation.volume | 17 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 379 | - |
dc.citation.endPage | 387 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.subject.keywordPlus | MAMMARY-TUMOR VIRUS | - |
dc.subject.keywordPlus | BREAST-CANCER | - |
dc.subject.keywordPlus | GENE-EXPRESSION | - |
dc.subject.keywordPlus | UROKINASE RECEPTOR | - |
dc.subject.keywordPlus | LYMPHOCYTE | - |
dc.subject.keywordPlus | DIFFERENTIATION | - |
dc.subject.keywordPlus | METASTASIS | - |
dc.subject.keywordPlus | CARCINOMA | - |
dc.subject.keywordPlus | ANTIGENS | - |
dc.subject.keywordAuthor | lymphocyte antigen 6 family member K | - |
dc.subject.keywordAuthor | lymphocytes | - |
dc.subject.keywordAuthor | T cell development | - |
dc.subject.keywordAuthor | thymus | - |
dc.subject.keywordAuthor | spleen | - |
dc.subject.keywordAuthor | breast cancer | - |
dc.subject.keywordAuthor | transgenic mouse model | - |
dc.identifier.url | https://www.spandidos-publications.com/10.3892/ol.2018.9548 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Sookmyung Women's University. Cheongpa-ro 47-gil 100 (Cheongpa-dong 2ga), Yongsan-gu, Seoul, 04310, Korea02-710-9127
Copyright©Sookmyung Women's University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.